Copyright Reports & Markets. All rights reserved.

Global Clinical Trial Services Market Research Report 2021

Request for Sample of this report
Buy now

1 Clinical Trial Services Market Overview

  • 1.1 Product Overview and Scope of Clinical Trial Services
  • 1.2 Clinical Trial Services Segment by Type
    • 1.2.1 Global Clinical Trial Services Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Phase 1
    • 1.2.3 Phase 2
    • 1.2.4 Phase 3
  • 1.3 Clinical Trial Services Segment by Application
    • 1.3.1 Clinical Trial Services Sales Comparison by Application: (2021-2027)
    • 1.3.2 Cancer
    • 1.3.3 Cardiovascular
    • 1.3.4 CNS
    • 1.3.5 Infectious Diseases
    • 1.3.6 Metabolic Diseases
    • 1.3.7 Other Diseases
  • 1.4 Global Clinical Trial Services Market Size Estimates and Forecasts
    • 1.4.1 Global Clinical Trial Services Revenue 2016-2027
    • 1.4.2 Global Clinical Trial Services Sales 2016-2027
    • 1.4.3 Clinical Trial Services Market Size by Region: 2016 Versus 2021 Versus 2027

2 Clinical Trial Services Market Competition by Manufacturers

  • 2.1 Global Clinical Trial Services Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Clinical Trial Services Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Clinical Trial Services Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Clinical Trial Services Manufacturing Sites, Area Served, Product Type
  • 2.5 Clinical Trial Services Market Competitive Situation and Trends
    • 2.5.1 Clinical Trial Services Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Clinical Trial Services Players Market Share by Revenue
    • 2.5.3 Global Clinical Trial Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Clinical Trial Services Retrospective Market Scenario by Region

  • 3.1 Global Clinical Trial Services Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Clinical Trial Services Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Clinical Trial Services Market Facts & Figures by Country
    • 3.3.1 North America Clinical Trial Services Sales by Country
    • 3.3.2 North America Clinical Trial Services Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Clinical Trial Services Market Facts & Figures by Country
    • 3.4.1 Europe Clinical Trial Services Sales by Country
    • 3.4.2 Europe Clinical Trial Services Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Clinical Trial Services Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Clinical Trial Services Sales by Region
    • 3.5.2 Asia Pacific Clinical Trial Services Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Clinical Trial Services Market Facts & Figures by Country
    • 3.6.1 Latin America Clinical Trial Services Sales by Country
    • 3.6.2 Latin America Clinical Trial Services Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Clinical Trial Services Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Clinical Trial Services Sales by Country
    • 3.7.2 Middle East and Africa Clinical Trial Services Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Clinical Trial Services Historic Market Analysis by Type

  • 4.1 Global Clinical Trial Services Sales Market Share by Type (2016-2021)
  • 4.2 Global Clinical Trial Services Revenue Market Share by Type (2016-2021)
  • 4.3 Global Clinical Trial Services Price by Type (2016-2021)

5 Global Clinical Trial Services Historic Market Analysis by Application

  • 5.1 Global Clinical Trial Services Sales Market Share by Application (2016-2021)
  • 5.2 Global Clinical Trial Services Revenue Market Share by Application (2016-2021)
  • 5.3 Global Clinical Trial Services Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Labcorp
    • 6.1.1 Labcorp Corporation Information
    • 6.1.2 Labcorp Description and Business Overview
    • 6.1.3 Labcorp Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Labcorp Product Portfolio
    • 6.1.5 Labcorp Recent Developments/Updates
  • 6.2 IQVIA
    • 6.2.1 IQVIA Corporation Information
    • 6.2.2 IQVIA Description and Business Overview
    • 6.2.3 IQVIA Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 IQVIA Product Portfolio
    • 6.2.5 IQVIA Recent Developments/Updates
  • 6.3 Syneos Health
    • 6.3.1 Syneos Health Corporation Information
    • 6.3.2 Syneos Health Description and Business Overview
    • 6.3.3 Syneos Health Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Syneos Health Product Portfolio
    • 6.3.5 Syneos Health Recent Developments/Updates
  • 6.4 Parexel
    • 6.4.1 Parexel Corporation Information
    • 6.4.2 Parexel Description and Business Overview
    • 6.4.3 Parexel Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Parexel Product Portfolio
    • 6.4.5 Parexel Recent Developments/Updates
  • 6.5 PRA
    • 6.5.1 PRA Corporation Information
    • 6.5.2 PRA Description and Business Overview
    • 6.5.3 PRA Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 PRA Product Portfolio
    • 6.5.5 PRA Recent Developments/Updates
  • 6.6 PPD
    • 6.6.1 PPD Corporation Information
    • 6.6.2 PPD Description and Business Overview
    • 6.6.3 PPD Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 PPD Product Portfolio
    • 6.6.5 PPD Recent Developments/Updates
  • 6.7 CRL
    • 6.6.1 CRL Corporation Information
    • 6.6.2 CRL Description and Business Overview
    • 6.6.3 CRL Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 CRL Product Portfolio
    • 6.7.5 CRL Recent Developments/Updates
  • 6.8 ICON
    • 6.8.1 ICON Corporation Information
    • 6.8.2 ICON Description and Business Overview
    • 6.8.3 ICON Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 ICON Product Portfolio
    • 6.8.5 ICON Recent Developments/Updates
  • 6.9 Wuxi Apptec
    • 6.9.1 Wuxi Apptec Corporation Information
    • 6.9.2 Wuxi Apptec Description and Business Overview
    • 6.9.3 Wuxi Apptec Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Wuxi Apptec Product Portfolio
    • 6.9.5 Wuxi Apptec Recent Developments/Updates
  • 6.10 Medpace Holdings
    • 6.10.1 Medpace Holdings Corporation Information
    • 6.10.2 Medpace Holdings Description and Business Overview
    • 6.10.3 Medpace Holdings Clinical Trial Services Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Medpace Holdings Product Portfolio
    • 6.10.5 Medpace Holdings Recent Developments/Updates

7 Clinical Trial Services Manufacturing Cost Analysis

  • 7.1 Clinical Trial Services Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Clinical Trial Services
  • 7.4 Clinical Trial Services Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Clinical Trial Services Distributors List
  • 8.3 Clinical Trial Services Customers

9 Clinical Trial Services Market Dynamics

  • 9.1 Clinical Trial Services Industry Trends
  • 9.2 Clinical Trial Services Growth Drivers
  • 9.3 Clinical Trial Services Market Challenges
  • 9.4 Clinical Trial Services Market Restraints

10 Global Market Forecast

  • 10.1 Clinical Trial Services Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Clinical Trial Services by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Clinical Trial Services by Type (2022-2027)
  • 10.2 Clinical Trial Services Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Clinical Trial Services by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Clinical Trial Services by Application (2022-2027)
  • 10.3 Clinical Trial Services Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Clinical Trial Services by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Clinical Trial Services by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Phase 1
    Phase 2
    Phase 3

    Segment by Application
    Cancer
    Cardiovascular
    CNS
    Infectious Diseases
    Metabolic Diseases
    Other Diseases

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Labcorp
    IQVIA
    Syneos Health
    Parexel
    PRA
    PPD
    CRL
    ICON
    Wuxi Apptec
    Medpace Holdings

    Buy now